stella
beta
UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells — Stella
Recruiting
Back to Adrenoleukodystrophy trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Duke University Medical Center, Durham, North Carolina
View full record on ClinicalTrials.gov